v3.3.0.814

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 445,821	$ 3,040,942
Restricted cash	36,751	39,563
Inventory	97,750	99,250
Prepaid expenses and other current assets	761,860	2,910,476
Total Current Assets	1,342,182	6,090,231
Long-Term Assets
Prepaid income taxes	5,980,486	8,575,810
Property and equipment, net	418,240	393,046
Intangible assets, net	50,995,384	56,022,289
Total Long-Term Assets	57,394,110	64,991,145
Total Assets	58,736,292	71,081,376
Current Liabilities
Accounts payable	3,873,932	2,709,551
Financial instruments	1,957,549	1,798,184
Accrued compensation	731,344	653,294
Accrued expenses and other liabilities	886,258	374,106
Notes Payable	800,000	0
Obligation under capital lease - current portion	4,254	0
Total Current Liabilities	8,253,337	5,535,135
Long-Term Liabilities
Income tax payable	6,704,486	8,814,027
Notes payable	3,000,000	3,000,000
Accrued interest	950,000	856,666
Deferred rent	65,476	0
Obligation under capital lease	35,745	0
Total Long-Term Liabilities	10,755,707	12,670,693
Total Liabilities	$ 19,009,044	$ 18,205,828
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.0001 par value: 50,000,000 shares authorized; 0 shares issued and outstanding	$ 0	$ 0
Common stock, $0.0001 par value; 200,000,000 shares authorized; 37,081,078 and 34,962,172 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	3,708	3,496
Additional paid-in capital	176,411,921	164,844,066
Accumulated deficit	(136,549,616)	(111,806,126)
Accumulated other comprehensive loss	(138,765)	(165,888)
Total Stockholders' Equity	39,727,248	52,875,548
Total Liabilities and Stockholders' Equity	$ 58,736,292	$ 71,081,376

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.

VACCINOGEN INC 10-Q